{"name":"STAT Therapeutics Inc","slug":"stat-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"naloxone IM","genericName":"naloxone IM","slug":"naloxone-im","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"naloxone IM","genericName":"naloxone IM","slug":"naloxone-im","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNb1NteWZrVXV0amxGQUdxcHM3TmwtS0hFd1BldEFFZGYyQnhRQTR6ZzUwTGdMbklQY0FucUlNR3BRRG5leGVaWGpqQTNJRGRNZDZ5Qm5rU21OVWZFNlBBSEFQVHgxMTBYTnU4bWQza3dXNjhkNUl6ZGRwWTVFbVQ1X3BJbUdoNW8?oc=5","date":"2026-03-25","type":"pipeline","source":"statnews.com","summary":"Sarepta Therapeutics shares rise on early promise for rare disease drugs - statnews.com","headline":"Sarepta Therapeutics shares rise on early promise for rare disease drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPcEFjWERLem9GQnBoQURhZ1FNcXBfbWhDamg3RmJJV202NE9yN2pqT3RMbmlTdG5wOGtHNmtsbEN0YUpSc2FESXRzUVBXdnRfZVZxUTkwTGpVUDlqSmhySWYySjZSZEN2eEFhXy12ZWNSQlVLa2ZtYVV4cTFOcy05b1pzVEc2dWsyR1NMZDhB?oc=5","date":"2026-03-12","type":"pipeline","source":"statnews.com","summary":"Is Aldeyra Therapeutics waving red flags with consequences? - statnews.com","headline":"Is Aldeyra Therapeutics waving red flags with consequences?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOZUhMTk14anN6Tk5hTV9nby1LU0Zmb1pPeXFpS3RsMG9TY0hRbmpreDlaSWhKVDV2RV9BWEx5bWQxWkpjaFIwQ0UzWXRKWVY0VUpXLVV1NUVUdG1ZMU9NT0NQRURMVVJuaGd4YWZLT1U2SnJEVEVJNlZnQmRRcjNTSjZfQk41QWwtLUdEcGJtRzFNaWdpd01VMUoyemJsenVxeXhxcU12VlBESm1aLV8zWkhJSGpCdlU?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"Major pharma and biotech companies by R&D growth - Statista","headline":"Major pharma and biotech companies by R&D growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBOaWVUTlVhcmdFcmctSGdsekp5SVVfblVxd2JRZXRfREdXakxPZEFWeFBJTm5NM0d6YjFPTTNwdG9MVkVGeS1tYlh2aWJvS2duODNkREtPajhtS1MtNUsybWZqNjFfVXUxZ2ZYVzNEZGlzQUVpMVgzYXZqbnU?oc=5","date":"2026-02-06","type":"pipeline","source":"statnews.com","summary":"A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all - statnews.com","headline":"A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE44X1hjSDBpeXhhLW5hNVQtNFJNYkROMFYwMTVmX0pCZFFYOU1oZmN6T0VfMXlwdmxlTGhzSXFMWjc1WkNrQl9udnpRczZhc2V1QVBTZHlxek5kS1JqbGhzMkNpWWxyNU5NSFFIbVdobzBCb0NjLW1wNXUtLWc?oc=5","date":"2025-10-27","type":"pipeline","source":"statnews.com","summary":"For Intellia Therapeutics, CRISPR drug’s safety concern is an existential threat - statnews.com","headline":"For Intellia Therapeutics, CRISPR drug’s safety concern is an existential threat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPYUh0cDVsbktqMkhpOGpIYWVVcmVrUFA1eTdlVzU5bnc5bmZ4LVhqbkM4T3JtYW5iTnhacVJUWnpoY1VzcVhhVjVIN3h4RktPR29vbjkxLXNQUEVOS0NoSUppaWMydm1YQ0dMaEpobmtDOEJKb2xhb2VWUi1OYS14Tm83blpLS2dYTVo4?oc=5","date":"2025-10-14","type":"pipeline","source":"statnews.com","summary":"Kailera Therapeutics, an obesity drug startup, raises $600 million - statnews.com","headline":"Kailera Therapeutics, an obesity drug startup, raises $600 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQYTZHZVZ0ZXBlS1pGYUNteVBQR1JYSkpLYVhDNzRQaFNwZncta3Aycl9KWG04TTJQZS02NHdsVVlYYzZqRTFLZjRyUVZkYUdwREtxOENaRnBmVndrUDNXdkphUURWdkhUYVBMVlpzVjctRUlPWnpkeWF6S1pVd0FlMzZ5ZXRnVlQ0d1E?oc=5","date":"2025-10-01","type":"pipeline","source":"Pharmaceutical Technology","summary":"Star Therapeutics gains $125m Series D funds to develop pipeline - Pharmaceutical Technology","headline":"Star Therapeutics gains $125m Series D funds to develop pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNcU5DbE1HVXpfVVdCWkRUSUlNRkk2aHRPMF8yVHdWOXkzekxfRHlzODlfUGM3bVVHYllNaFdRNERRX2c1QlFQYkRPb201dkdhYkJXSHdNOXhvN2RZUlZMVjQ1MUFYUkVIdHlMd0pwTk9kWm8zVUM3Z2VER3VsclBIYl85dkRtSTBYSkFySQ?oc=5","date":"2025-09-30","type":"pipeline","source":"BioPharma Dive","summary":"Star raises another $125M for its blood disease drug - BioPharma Dive","headline":"Star raises another $125M for its blood disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOeERsdnpXOU1MWmZEZ2lZWWZBdGlHazdoLWZnSTBPaUtKRjJqV1l1dHpfSDZRM05RYnloTTFvOUo0ZDRwRHdMTkZCWWpOeFVRa1FQeWFvWUt0bkd3R3RjRGliTVo5UEZFLXBkaDFzTHRFRS1ua2puWW11UG1CTWgxdTJtdm9LUm1MVDRCZUJVQ21iTVVrX18yVmh3LXMzUDYzd2t6UzZBMFhLZFlpMjYwNjNXRkdvaHU2V053SVpPbFc3S1dOVHc?oc=5","date":"2025-09-30","type":"pipeline","source":"Fierce Biotech","summary":"Star Therapeutics collects shiny $125M funding boost to push bleeding disorder prospect into orbit - Fierce Biotech","headline":"Star Therapeutics collects shiny $125M funding boost to push bleeding disorder prospect into orbit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE92eFpSaUZ0RlpMU3lQTWJ5QVRTNkdUWDJkdXFUMVlDSzBrVGpQMGtlZURxcDlKYmZheElMZFhldEpfSkpkTm5zMktqcVZmQ1JMVWV6OG0zOGlqNVNfdk0tc2hBSFBjUkx2WFVFUk1mZEtGeTlrTWxnSmlXM3Z2SXc?oc=5","date":"2025-08-19","type":"trial","source":"statnews.com","summary":"Viking Therapeutics oral weight loss drug hits mark in mid-stage trial but disappoints investors - statnews.com","headline":"Viking Therapeutics oral weight loss drug hits mark in mid-stage trial but disappoints investors","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQdE13ZUZzbjVLeUNwSDRDRUdwMzF2Vjk3SjkyZUVVYzZJemM2eGNkUVBsaE92QWVoR3hBTFVZUEJTRmRVUEt5RnJSTjNkRlBRNG9qNHluY2hrdmNxMERNWGREZHhTeEV4NUtfc0lQcGYyNWtLaEM0VURzQnZzNm5Gd0F3Slg?oc=5","date":"2025-07-28","type":"regulatory","source":"statnews.com","summary":"FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt - statnews.com","headline":"FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}